Author: Dr Gavin Esson, Foundation Trainee, NHS Lothian, Edinburgh, Scotland. DermNet Editor in Chief: Adjunct A/Prof. Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy edited by Gus Mitchell/Maria McGivern. December 2018.
Congenital secondary hypogonadism results from isolated gonadotropin deficiency due to geneticmutations, such as Kallmann syndrome, Prader–Willi syndrome, and other similar conditions.
Acquired secondary hypogonadism
Acquired secondary hypogonadism may result from:
Damage to the pituitary or hypothalamus, including:
Intracranial space-occupying lesions (eg, tumours and cysts)
Hyperprolactinaemia (an excess of the milk-inducing hormone prolactin).
What are the clinical features of hypogonadism in males?
The clinical features of hypogonadism depend on the patient's age at presentation.
Testosterone deficiency at birth
Hypogonadism at birth may be recognised by ambiguous genitalia (external genitals that are neither clearly male nor clearly female).
Testosterone deficiency pre-puberty
Hypogonadism pre-puberty may be diagnosed by the failure to undergo or complete puberty. The boy may have a young appearance, lack pubic hair, have small genitalia and testes, his voice may fail to break, and he may have difficulty in gaining muscle.
Testosterone deficiency after completion of puberty
After the completion of puberty, the features of hypogonadism include decreased libido, erectile dysfunction, osteoporosis, depression, gynaecomastia, shrinking of the testes, and infertility. After some years of testosterone deficiency, decreased muscle mass and body hair may be evident.
What skin changes may be due to hypogonadism in males?
Androgens are responsible for sebaceous gland growth and differentiation, hair growth, and epidermal barrier homeostasis [1].
Androgen deficiency results in:
Dry, thin, and wrinkled skin
Lack of hair growth on the chest, axilla, face, and genitals
Lack of genitalpigmentation
Gynaecomastia
Reduced incidence of acne [2,3].
How is hypogonadism in males diagnosed?
The diagnosis of hypogonadism is based on observing typical clinical features in a man with low serum testosterone. The patient should be referred to a specialist.
Initial investigations should include measuring LH, FSH, and serum testosterone (usually taken in the morning, and repeated at least twice). If testosterone is low:
Elevated LH and FSH suggest primary hypogonadism
Low LH and FSH suggest secondary hypogonadism.
Further investigations should be directed at identifying the underlying cause.
What is the treatment and outcome for hypogonadism in males?
Effective testosterone replacement in men with hypogonadism has been showed to maintain secondary sexual characteristics, increase libido, muscle strength, fat-free mass, and bone density [4].
Adverse effects of testosterone replacement include:
Stimulation of the growth of breast cancer or prostate cancer
Sleep apnoea
Heart failure
Erythrocytosis.
What are the contraindications to testosterone therapy?
Testosterone should not be started in individuals with breast cancer, prostate cancer or an increased risk of prostate cancer, haematocrit above 50%, untreated obstructive sleep apnoea, severe lower urinary tract symptoms, or uncontrolled heart failure [4].
References
Zouboulis CC, Degitz K. Androgen action on human skin — from basic research to clinical significance. Exp Dermatol 2004; 13 Suppl 4: 5–10. PubMed
Kohn FM, Ring J, Schill WB. [Dermatological aspects of male hypogonadism]. Hautarzt 2000, 51: 223–30. [German] PubMed
Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 2536–59. DOI: 10.1210/jc.2009-2354. PubMed